Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis.


  1. Home


  2. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis.


  3. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis.

Carragee EJ, Chu G, Rohatgi R, Hurwitz EL, Weiner BK, Yoon ST, Comer G, Kopjar B. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. J Bone Joint Surg Am. 2013 Sep 4;95(17):1537-45. doi: 10.2106/JBJS.L.01483.

Upcoming Events

Full Calendar


News Categories